Results 171 to 180 of about 134,137 (295)

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Myocarditis in malaria—current evidence and future directions: a literature review [PDF]

Gbolahan Olatunji, Emmanuel Kokori, Ikponmwosa Jude Ogieuhi, Olumide Akinmoju, Oluwatobi Omoworare, Doyin Olatunji, David Timilehin Isarinade, God-dowell O. Odukudu, Israel Charles Abraham, Samuel Owolabi, Jamil Nasrallah, Emmanuel Egbunu, Babafemi Jaiyeoba, Ismaila Ajayi Yusuf, Olawale Olanisa, Nicholas Aderinto   +15 more
openalex   +1 more source

Risk factors for adverse cardiac events in adults with fulminant myocarditis during hospitalization

, 2020
Tieduo Kang, Yanlong Ren, Han Zhao, Shangqiu Ning, Wenxian Liu   +4 more
openalex   +2 more sources

Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

Cell Proliferation, EarlyView.
HDACs play an important role in the occurrence and development of cardiovascular diseases, such as myocardial hypertrophy, hypertension, and atherosclerosis. HDAC inhibitors have broad prospects for the treatment of CVD, and different HDAC subtypes can act through different mechanisms.
Li‐Ying Zhang, Yue‐Yue Wang, Ri Wen, Tie‐Ning Zhang, Ni Yang   +4 more
wiley   +1 more source

Nationwide estimates of SARS‐CoV‐2 infection fatality rates and numbers needed to vaccinate for COVID‐19 vaccines in 2024 in Austria

European Journal of Clinical Investigation, EarlyView.
In 2024, Austria's infection fatality rate (IFR) for SARS‐CoV‐2 was .048%, indicating a low COVID‐19 mortality risk. Using literature‐based vaccine effectiveness estimates, numbers needed to vaccinate (NNV) to prevent one death and one life‐year saved (LYS) were extremely high across all age groups, except among the very old.
Uwe Riedmann, Martin Sprenger, John P. A. Ioannidis, Stefan Pilz   +3 more
wiley   +1 more source

Protective association of renin‐angiotensin system inhibitor use with skeletal muscle wasting in diabetic heart failure

Journal of Diabetes Investigation, EarlyView.
In heart failure, renin‐angiotensin system inhibitor (RASI) use was associated with less skeletal muscle wasting in patients with diabetes, but not in those without diabetes (significant interaction). The association in diabetes was more evident at lower plasma 3‐methylhistidine levels than at higher levels, suggesting a potential biomarker‐defined ...
Hidemichi Kouzu, Toshiyuki Yano, Satoshi Katano, Wataru Kawaharata, Ryo Numazawa, Ryohei Nagaoka, Hiroki Aida, Katsuhiko Ohori, Takefumi Fujito, Nobutaka Nagano, Masato Furuhashi   +10 more
wiley   +1 more source

Comparison of Immune Checkpoint Inhibitor (ICI) Myocarditis and Non-ICI Myocarditis Using Cardiovascular Magnetic Resonance: A Single-Centre Retrospective Observational Study. [PDF]

J Clin Med
Jacobs E, Yip A, Hodge A, McLean D, Lee J, Parish V, Ellery S, Olsson-Brown A, Liu A.   +8 more
europepmc   +1 more source

The Periodontal Pathogen <I>Aggregatibacter Actinomycetemcomitans</I> Affects Experimental Autoimmune Myocarditis in Mice

, 2013
Norihiko Ashigaki, Jun‐ichi Suzuki, Norio Aoyama, Masahito Ogawa, Ryo Watanabe, Naho Kobayashi, Issei Komuro, Yuichi Izumi, Mitsuaki Isobe   +8 more
openalex   +2 more sources

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang, Keneshka Atash, Nicolaas P. A. Zuithoff, Inge Haeck, Celeste M. Boesjes, Octavian I. Bacoş‐Cosma, Laura Loman, Marijke Kamsteeg, Simone Stadhouders‐Keet, Albert J. Oosting, Anneke M. T. van Lynden‐van Nes, Klaziena Politiek, Antoni Gostynksi, Lisette Berntsen‐Zandbergen, Wianda A. Christoffers, Annebeth Flinterman, Wouter R. H. Touwslager, Berit Velstra, Shiarra M. Stewart, Francine C. van Erp, Marlies de Graaf, Marie‐Louise A. Schuttelaar, Marjolein S. de Bruin‐Weller   +22 more
wiley   +1 more source

The First Report of Cod Gill Poxvirus in Gills of Atlantic Cod (Gadus morhua L.) Suffering From Cardiorespiratory Disease

Journal of Fish Diseases, Volume 48, Issue 4, April 2025.
ABSTRACT Atlantic cod farming experiences renewed growth in Norway, and increased awareness is essential to address emerging diseases in this species. There are few reports on gill diseases in cod, and to date, no viral gill infections of cod have been documented. In this study, we collected samples from three sequential time points in summer 2023 from
Mona C. Gjessing, Torstein Tengs, Hanne Nilsen, Saima Mohammad, Simon C. Weli   +4 more
wiley   +1 more source